Psychedelic plants, fungi and synthesised or extracted substances might not be considered technologies in and of themselves. But in the broader sense, if how and why they are used are considered as a whole, they are. This unequivocally applies to the development of psychedelic-assisted therapies and any commercialisation of psychedelics, whether the intended use is strictly medical or not. In this longer ‘deep dive’ piece, I’m going to look at commercial psychedelic therapy through this lens of the ethics of technological design. This is not as in-depth a treatment as I can possibly produce, but rather, is a pointer in…








Samuel Douglas

Philosopher and educator. Interested in teaching, ethical dilemmas, cryptocurrency and psychedelia.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store